CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,840,796 | +34.8% | 1,611,702 | +55.0% | 0.19% | +41.2% |
Q2 2023 | $13,977,439 | +36.9% | 1,039,988 | +68.8% | 0.14% | +33.3% |
Q1 2023 | $10,212,749 | +3.2% | 615,968 | +15.8% | 0.10% | -1.9% |
Q4 2022 | $9,893,135 | +17.1% | 531,889 | -19.2% | 0.10% | +8.3% |
Q3 2022 | $8,449,000 | -42.6% | 658,547 | -68.6% | 0.10% | -36.8% |
Q2 2022 | $14,723,000 | -21.5% | 2,100,225 | -7.1% | 0.15% | -4.4% |
Q1 2022 | $18,751,000 | +7.2% | 2,261,907 | -12.5% | 0.16% | +21.4% |
Q4 2021 | $17,493,000 | +9.8% | 2,583,868 | -14.1% | 0.13% | +10.1% |
Q3 2021 | $15,937,000 | -9.8% | 3,006,994 | -2.2% | 0.12% | -1.7% |
Q2 2021 | $17,675,000 | +18.0% | 3,073,846 | -5.4% | 0.12% | +19.8% |
Q1 2021 | $14,981,000 | +86.5% | 3,249,650 | +35.1% | 0.10% | +53.0% |
Q4 2020 | $8,033,000 | +51.5% | 2,405,129 | +34.7% | 0.07% | +15.8% |
Q3 2020 | $5,301,000 | -12.4% | 1,784,890 | +36.3% | 0.06% | -14.9% |
Q2 2020 | $6,052,000 | +144.1% | 1,309,906 | +103.4% | 0.07% | +97.1% |
Q1 2020 | $2,479,000 | -15.3% | 643,991 | -17.5% | 0.03% | +30.8% |
Q4 2019 | $2,928,000 | – | 780,782 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |